PRESS RELEASE published on 12/11/2023 at 10:00, 2 years 7 months ago Tryp Therapeutics Inc. Announces Signing of Definitive Agreement with Exopharm Limited
PRESS RELEASE published on 11/20/2023 at 12:00, 2 years 8 months ago Tryp Therapeutics Announces Closing of Oversubscribed Private Placement of Unsecured Convertible Notes for Gross Proceeds of AUD$3,215,000
PRESS RELEASE published on 11/02/2023 at 11:00, 2 years 8 months ago Tryp Therapeutics Inc. Announces Private Placement of Unsecured Convertible Notes for Gross Proceeds of AUD$3.0 Million
PRESS RELEASE published on 10/11/2023 at 22:30, 2 years 9 months ago Tryp Therapeutics Announces Closing of Private Placement of Unsecured Convertible Debentures for Gross Proceeds of AUD$175,000
PRESS RELEASE published on 08/03/2023 at 12:00, 2 years 11 months ago Tryp Therapeutics Announces Jason Carroll as New Chief Executive Officer
PRESS RELEASE published on 08/02/2023 at 12:00, 2 years 11 months ago With Great Sadness Tryp Announces the Passing of David Tousley, Director
PRESS RELEASE published on 07/13/2023 at 12:00, 3 years ago Tryp Therapeutics Receives Confirmation From FDA To Proceed With Phase 2A Clinical Trial in Patients With IBS at Massachusetts General Hospital
PRESS RELEASE published on 05/24/2023 at 12:00, 3 years 1 month ago Tryp Therapeutics Submits Investigational New Drug (IND) Application to US FDA for Planned Phase 2a Clinical Trial in Patients With IBS at Massachusetts General Hospital
PRESS RELEASE published on 04/27/2023 at 12:00, 3 years 2 months ago Tryp Therapeutics Announces Closing of Oversubscribed Private Placement of Secured Convertible Debentures for Gross Proceeds of AUD$2,400,000
PRESS RELEASE published on 04/12/2023 at 22:00, 3 years 3 months ago Tryp Therapeutics Announces Private Placement of Secured Convertible Debentures for Gross Proceeds of a Minimum of AUD$2,000,000
Published on 07/21/2026 at 23:00, 2 hours 51 minutes ago Viemed Healthcare Announces Second Quarter 2026 Earnings Conference Call Details
Published on 07/21/2026 at 22:30, 3 hours 21 minutes ago Fermi Announces First Siemens Turbines Arrive at Port of Houston
Published on 07/21/2026 at 22:30, 3 hours 21 minutes ago Matador Technologies Announces Management Transition
Published on 07/21/2026 at 22:15, 3 hours 36 minutes ago Vanta Announces Updated Time for Participation in the "Health, Wellness & Longevity" Virtual Conference Presented by Maxim Group LLC on Wednesday, July 22, 2026, at 12:00 p.m. ET
Published on 07/21/2026 at 22:00, 3 hours 51 minutes ago Redwood AI Announces Closing of $3.5 Million Private Placement
Published on 07/22/2026 at 01:05, 46 minutes ago Quantinuum and SoftBank Corp. Publish Joint White Paper on Scaling Practical Quantum Computing Use Cases Toward the Fault-Tolerant Era
Published on 07/21/2026 at 22:30, 3 hours 21 minutes ago Strong second quarter: GEA raises full-year guidance for 2026
Published on 07/21/2026 at 22:16, 3 hours 35 minutes ago EQS-Adhoc: GEA Group Aktiengesellschaft: Preliminary numbers for Q2 2026 exceed market expectation - increase of guidance for fiscal year 2026
Published on 07/21/2026 at 18:50, 7 hours 1 minute ago Soapeya, a DN Group AG Portfolio Company, Earns Top "Excellent" Rating from Dermatest and Proves Successful in Field Use in Ghana
Published on 07/21/2026 at 18:15, 7 hours 36 minutes ago EuroTeleSites Reports Strong Q2/2026 Results with Growth Across Key Financial and Operating Metrics
Published on 07/20/2026 at 18:20, 1 day 7 hours ago Covivio - 2026 Half-year results: Earnings growth driven by active asset management
Published on 07/20/2026 at 18:04, 1 day 7 hours ago Reporting on share buyback transactions carried out between July 8 and July 9, 2026
